105 related articles for article (PubMed ID: 10869552)
1. Secondary structure of the 5'-region of PGY1/MDR1 mRNA.
Kostenko EV; Beabealashvilly RS; Vlassov VV; Zenkova MA
FEBS Lett; 2000 Jun; 475(3):181-6. PubMed ID: 10869552
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of PGY1/MDR1 mRNA level in human KB cells by antisense oligonucleotide conjugates. RNA accessibility in vitro and intracellular antisense activity.
Kostenko EV; Laktionov PP; Vlassov VV; Zenkova MA
Biochim Biophys Acta; 2002 Jun; 1576(1-2):143-7. PubMed ID: 12031494
[TBL] [Abstract][Full Text] [Related]
3. [Secondary structure of 5'-terminal region of mRNA of human multidrug resistance gene].
Kostenko EV; Bibilashvili RSh; Vlasov VV; Zenkova MA
Mol Biol (Mosk); 2000; 34(1):67-78. PubMed ID: 10732342
[No Abstract] [Full Text] [Related]
4. 5'-bis-pyrenylated oligonucleotides displaying excimer fluorescence provide sensitive probes of RNA sequence and structure.
Kostenko E; Dobrikov M; Pyshnyi D; Petyuk V; Komarova N; Vlassov V; Zenkova M
Nucleic Acids Res; 2001 Sep; 29(17):3611-20. PubMed ID: 11522831
[TBL] [Abstract][Full Text] [Related]
5. Potent antisense oligonucleotides to the human multidrug resistance-1 mRNA are rationally selected by mapping RNA-accessible sites with oligonucleotide libraries.
Ho SP; Britton DH; Stone BA; Behrens DL; Leffet LM; Hobbs FW; Miller JA; Trainor GL
Nucleic Acids Res; 1996 May; 24(10):1901-7. PubMed ID: 8657572
[TBL] [Abstract][Full Text] [Related]
6. Identification of secondary structure in the 5'-untranslated region of the human adrenomedullin mRNA with implications for the regulation of mRNA translation.
Brenet F; Dussault N; Delfino C; Boudouresque F; Chinot O; Martin PM; Ouafik LH
Oncogene; 2006 Oct; 25(49):6510-9. PubMed ID: 16715138
[TBL] [Abstract][Full Text] [Related]
7. The Role of Structural Elements of the 5'-Terminal Region of p53 mRNA in Translation under Stress Conditions Assayed by the Antisense Oligonucleotide Approach.
Swiatkowska A; Zydowicz P; Gorska A; Suchacka J; Dutkiewicz M; Ciesiołka J
PLoS One; 2015; 10(10):e0141676. PubMed ID: 26513723
[TBL] [Abstract][Full Text] [Related]
8. Catalytic DNA and RNA for targeting MDR1 mRNA.
Kuznetsova M; Fokina A; Lukin M; Repkova M; Venyaminova A; Vlassov V
Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):1521-3. PubMed ID: 14565457
[TBL] [Abstract][Full Text] [Related]
9. [Structural characteristics of osteopontin mRNA].
Berezovskaia OP; Sidorenko AP; Mukha DV
Tsitol Genet; 2001; 35(3):35-42. PubMed ID: 11785431
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of gene expression inside cells by peptide nucleic acids: effect of mRNA target sequence, mismatched bases, and PNA length.
Doyle DF; Braasch DA; Simmons CG; Janowski BA; Corey DR
Biochemistry; 2001 Jan; 40(1):53-64. PubMed ID: 11141056
[TBL] [Abstract][Full Text] [Related]
11. Modulation of multidrug resistance in human leukemia cells with mdr1-targeted antisense oligonucleotides using variable treatment schedules.
Dassow H; Lassner D; Remke H; Preiss R
Int J Clin Pharmacol Ther; 2000 Apr; 38(4):209-16. PubMed ID: 10783831
[TBL] [Abstract][Full Text] [Related]
12. Effect of unmodified triple helix-forming oligodeoxyribonucleotide targeted to human multidrug-resistance gene mdr1 in MDR cancer cells.
Scaggiante B; Morassutti C; Tolazzi G; Michelutti A; Baccarani M; Quadrifoglio F
FEBS Lett; 1994 Oct; 352(3):380-4. PubMed ID: 7926005
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the human multidrug resistance protein containing mutations in the ATP-binding cassette signature region.
Bakos E; Klein I; Welker E; Szabó K; Müller M; Sarkadi B; Váradi A
Biochem J; 1997 May; 323 ( Pt 3)(Pt 3):777-83. PubMed ID: 9169612
[TBL] [Abstract][Full Text] [Related]
14. Structure of translation initiation region of c-myc mRNA and thermostability of the c-myc mRNA/antisense ODN complex.
Tanaka T; Kurihara Y; Sakamoto T; Furusawa M; Kobayashi A; Katahira M; Takeuchi K; Sugimoto N; Uesugi S
Nucleic Acids Symp Ser; 1995; (34):135-6. PubMed ID: 8841589
[TBL] [Abstract][Full Text] [Related]
15. Antisense inhibition of gene expression in cells by oligonucleotides incorporating locked nucleic acids: effect of mRNA target sequence and chimera design.
Braasch DA; Liu Y; Corey DR
Nucleic Acids Res; 2002 Dec; 30(23):5160-7. PubMed ID: 12466540
[TBL] [Abstract][Full Text] [Related]
16. Identification of sequences in rotavirus mRNAs important for minus strand synthesis using antisense oligonucleotides.
Barro M; Mandiola P; Chen D; Patton JT; Spencer E
Virology; 2001 Sep; 288(1):71-80. PubMed ID: 11543659
[TBL] [Abstract][Full Text] [Related]
17. The human mdr1 (multidrug-resistance) gene harbours a long homopyrimidine.homopurine sequence next to a cluster of Alu repeated sequences in intron 14.
Pauly M; Kayser I; Schmitz M; Ries F; Hentges F; Dicato M
Gene; 1995 Feb; 153(2):299-300. PubMed ID: 7875611
[TBL] [Abstract][Full Text] [Related]
18. Identifying Suitable Target Regions and Analyzing Off-Target Effects of Therapeutic Oligonucleotides.
Pedersen L; Hagedorn PH; Koch T
Methods Mol Biol; 2019; 2036():261-282. PubMed ID: 31410803
[TBL] [Abstract][Full Text] [Related]
19. Reversal MDR in breast carcinoma cells by transfection of ribozyme designed according the secondary structure of mdr1 mRNA.
Gao P; Zhou GY; Zhang QH; Li H; Mu K; Yuan YP; Zhang J; Wang BH
Chin J Physiol; 2006 Apr; 49(2):96-103. PubMed ID: 16830791
[TBL] [Abstract][Full Text] [Related]
20. Specific roles of 5' RNA secondary structures in stabilizing transcripts in chloroplasts.
Suay L; Salvador ML; Abesha E; Klein U
Nucleic Acids Res; 2005; 33(15):4754-61. PubMed ID: 16116040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
